Colson Hicks Eidson has extensive experience representing victims in products liability actions who have suffered from taking prescription and over-the-counter drugs.
Defective medical devices cause catastrophic harm to patients who receive them. When a defective device injures you or a loved one, you deserve the opportunity to seek justice against negligent parties responsible for your pain and losses. One medical device currently on the market that has known complications is transvaginal mesh. Women who have experienced serious side effects after undergoing transvaginal mesh surgery can consult our drug injury lawyers for free legal advice.
Throughout our more than 40 years of legal experience, we have led charges against companies that made defective or dangerous products. This led to favorable solutions for our clients and new policies that protected additional consumers from the same dangers. Review our verdicts and settlements page to learn more about our success stories for victims of defective products.
Transvaginal mesh is a type of surgical mesh used to treat pelvic prolapse, also known as pelvic organ prolapse (POP). Pelvic organs, such as the bladder, can fall out of place and drop down to where they push on the vaginal walls. POP often results from a weakening or stretching of the muscles that hold the pelvic organs in place, which can be caused by childbirth, menopause or a hysterectomy.
Women suffering from a prolapsed pelvic organ may experience discomfort and incontinence. A transvaginal mesh can be implanted to strengthen the vaginal wall and serve as a sling for the prolapsed organ. It is also used to treat stress urinary incontinence (SUI).
Manufacturers of transvaginal mesh products include:
The U.S. Food and Drug Administration (FDA) has received reports of transvaginal mesh complications, including:
If you or a loved one has experienced any of these complications after being treated with a transvaginal mesh, let our pharmaceutical attorneys protect your rights and stand up to the manufacturer. Our firm is respected as a leader in products liability litigation and has a solid history of successfully representing plaintiffs in pharmaceutical litigation.
In October 2008, the FDA issued a public health notice about the potential transvaginal mesh complications. It updated this notice in July 2011 to inform healthcare professionals and patients that complications following POP treatment with surgical mesh are not rare. Between 2005 and 2007, the FDA received over 1,000 reports of adverse events, and the agency received another 2,874 reports between Jan. 1, 2008 and Dec. 31, 2010. The FDA has identified mesh erosion into the vagina as the most frequent complication.
Our firm is evaluating cases involving various brands of transvaginal mesh complications. If you or a loved one suffered adverse side effects following treatment for POP or SUI with a transvaginal mesh product, contact our transvaginal mesh lawyers today for a free, no risk consultation. Our dedicated legal team is prepared to confront manufacturers on behalf of the women they have harmed.